Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Cancer. 2013 Mar 1;119(11):10.1002/cncr.28026. doi: 10.1002/cncr.28026

Table 1.

Absolute lymphocyte count distribution

Variable Total (n=399) ALC < 500 cells/μl (n=34) ALC ≥ 500 cells/μl (n=365) P-value*
Age at Diagnosis (%)
 1 to 9 years 293 21 (7.2) 272 (92.8) .107
 ≥ 10 years 106 13 (12.3) 93 (87.7)
Leukocyte count (%)
 < 50 × 103/μL 293 25 (8.5) 268 (91.5) .989
 ≥ 50 × 103/μL 106 9 (8.5) 97 (91.5)
MRD (%)
 Negative (< 0.01%) 318 19 (6.0) 299 (94.0) .005
 Positive (≥ 0.01%) 77 13 (16.9) 64 (83.1)
 Missing 4 2 (50.0) 2 (50.0)
Lineage (%)
 B 336 19 (5.7) 317 (94.3) < .001
 T 63 15 (23.8) 48 (76.2)
Initial risk group (%)
 Low 223 10 (4.5) 213 (95.5) .001
 Standard/High 176 24 (13.6) 152 (86.4)

ALC, absolute lymphocyte count; MRD, minimal residual disease

*

Pearson’s chi-square test